Esperion Therapeutics, Inc.
ESPR · NASDAQ
Bulios Fair Price
$3.45
8.5% upside
Current Price
$3.18
According to Bulios Fair Price, ESPR is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Esperion Therapeutics, Inc. is an American biopharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative therapies to lower cholesterol and prevent cardiovascular disease. The company primarily targets patients who are unable to achieve their cholesterol goals with commonly available statins, offering alternative treatment options aimed at improving quality of life and reducing the risk of cardiac events.
Sector
Healthcare
Industry
Biotechnology
CEO
Sheldon L. Koenig
Employees
294
Headquarters
Ann Arbor